CANDEL THERAPEUTICS, INC. Investing Cash Flow
CANDEL THERAPEUTICS, INC. (CADL) reported Investing Cash Flow of -$744.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-13
- CANDEL THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$69.00K.
- CANDEL THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$675.00K.
- CANDEL THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$409.00K.
- CANDEL THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$117.00K.
- CANDEL THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2025 was -$560.00K.
- CANDEL THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$16.00K.
- CANDEL THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$280.00K.
- CANDEL THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$1.30M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$69.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$744.00K 10-Q · filed 2026-08-13 | -$1.15M derived: sum of 3 quarters · filed 2026-08-13 | -$1.27M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$675.00K 10-Q · filed 2026-05-14 | -$1.08M derived: sum of 2 quarters · filed 2026-05-14 | -$1.20M derived: sum of 3 quarters · filed 2026-05-14 | -$1.23M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$409.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$526.00K derived: sum of 2 quarters · filed 2026-03-12 | -$557.00K derived: sum of 3 quarters · filed 2026-08-13 | -$560.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | -$117.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$148.00K derived: sum of 2 quarters · filed 2026-08-13 | -$151.00K 10-Q · filed 2025-11-13 | -$154.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$34.00K 10-Q · filed 2026-08-13 | -$37.00K derived: sum of 3 quarters · filed 2026-08-13 | -$37.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$3.00K 10-Q · filed 2026-05-14 | -$6.00K derived: sum of 2 quarters · filed 2026-05-14 | -$6.00K derived: sum of 3 quarters · filed 2026-05-14 | -$12.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$3.00K derived: sum of 2 quarters · filed 2026-03-12 | -$9.00K derived: sum of 3 quarters · filed 2026-03-12 | -$16.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$6.00K derived: sum of 2 quarters · filed 2025-11-13 | -$13.00K 10-Q · filed 2025-11-13 | -$40.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$13.00K 10-Q · filed 2025-08-14 | -$40.00K derived: sum of 3 quarters · filed 2025-08-14 | -$143.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$7.00K 10-Q · filed 2025-05-13 | -$34.00K derived: sum of 2 quarters · filed 2025-05-13 | -$137.00K derived: sum of 3 quarters · filed 2025-05-13 | -$306.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$130.00K derived: sum of 2 quarters · filed 2025-03-13 | -$299.00K derived: sum of 3 quarters · filed 2025-03-13 | -$280.00K 10-K · filed 2025-03-13 |
| 2023-09-30 | -$103.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$272.00K derived: sum of 2 quarters · filed 2024-11-14 | -$253.00K 10-Q · filed 2024-11-14 | -$529.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$169.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$150.00K 10-Q · filed 2024-08-13 | -$426.00K derived: sum of 3 quarters · filed 2024-08-13 | -$641.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $19.00K 10-Q · filed 2024-05-14 | -$257.00K derived: sum of 2 quarters · filed 2024-05-14 | -$472.00K derived: sum of 3 quarters · filed 2024-05-14 | -$1.11M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$276.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$491.00K derived: sum of 2 quarters · filed 2024-03-28 | -$1.13M derived: sum of 3 quarters · filed 2024-03-28 | -$1.30M 10-K · filed 2024-03-28 |
| 2022-09-30 | -$215.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$850.00K derived: sum of 2 quarters · filed 2023-11-09 | -$1.02M 10-Q · filed 2023-11-09 | -$1.52M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$635.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$806.00K 10-Q · filed 2023-08-10 | -$1.31M derived: sum of 3 quarters · filed 2023-08-10 | -$1.70M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$171.00K 10-Q · filed 2023-05-11 | -$675.00K derived: sum of 2 quarters · filed 2023-05-11 | -$1.07M derived: sum of 3 quarters · filed 2023-05-11 | -$1.78M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$504.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$896.00K derived: sum of 2 quarters · filed 2023-03-30 | -$1.61M derived: sum of 3 quarters · filed 2023-03-30 | -$1.83M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$392.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$1.10M derived: sum of 2 quarters · filed 2022-11-10 | -$1.33M 10-Q · filed 2022-11-10 | $18.85M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$710.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$939.00K 10-Q · filed 2022-08-05 | $19.24M derived: sum of 3 quarters · filed 2022-08-05 | $18.51M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | -$229.00K 10-Q · filed 2022-05-12 | $19.95M derived: sum of 2 quarters · filed 2022-05-12 | $19.22M derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $20.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $19.45M derived: sum of 2 quarters · filed 2022-03-29 | $38.45M 10-K · filed 2022-03-29 | |
| 2020-09-30 | -$732.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $18.27M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $19.00M 10-Q · filed 2021-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |